Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cordis

This article was originally published in The Gray Sheet

Executive Summary

Releases Predator line of over-the-wire percutaneous transluminal coronary angioplasty catheters the week of March 14 at the American College of Cardiology annual meeting in Atlanta. The devices were among the spate of Cordis catheters approved in the summer of 1993 ("The Gray Sheet" Jan. 17, S-1). Cordis delayed introduction of the product until after the Olympix and Sleek PTCA catheter rollouts and until manufacturing capacity was ramped up. The company also has a line of approved diagnostic catheters that it has yet to launch
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002029

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel